Stellate Ganglion Destruction With Alcohol Versus Thermal Ablation for Chronic Post Mastectomy Pain

NCT ID: NCT05771103

Last Updated: 2023-08-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

70 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-01-01

Study Completion Date

2023-07-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

* Group A: SGB with alcohol injection by ultrasound guidance and C7 level confirmation by fluoroscopy.
* Group B: Thermal RF; thermal RF neurolysis will be applied with a time of 60 seconds at 80º C, and then will be repeated twice . Stellate ganglion RF therapy will be done under fluoroscopy, integrated by ultrasound guidance

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Breast cancer is the most common cause of cancer death for women . Postmastectomy pain syndrome (PMPS) is a frequent complication of breast surgery, and is considered a chronic neuropathic pain in the side of surgery which persists more than 3 months.

Complex regional pain syndrome (CRPS) is a clinical diagnosis with a highly variable presentation and prognosis. CRPS type I, previously known as reflex sympathetic dystrophy (RSD), is not associated with direct nerve injury. CRPS type II, or causalgia, is associated with direct injury of a specific nerve often from surgical intervention or trauma.

The stellate ganglion (SG), also known as the cervico-thoracic ganglion, is part of the sympathetic nervous system.

After assessment of eligibility criteria a predetermined randomization list and will be generated using random blocks.

* Group A: SGB with alcohol injection by ultrasound guidance and C7 level confirmation by fluoroscopy.
* Group B: Thermal RF; thermal RF neurolysis will be applied with a time of 60 seconds at 80º C, and then will be repeated twice has to be 0.5 cm apart from each other . Stellate ganglion RF therapy will be done under fluoroscopy, integrated by ultrasound guidance
* Group A ,The procedure will be started by placing the needle tip аntеrоlаteral to the lоngusсоlli muscle, dееp to the prеvеrtebrаlfаsсia in оrdеr tо аvоid spread along the carotid sheath, but superficial to the fascia investing the longus colli muscle (to prevent injecting into the muscle). Identifying the correct fascial plane achieved with portable ultrasound guidance thus facilitating the caudal spread of the injectate to reach the stellate ganglion at the C7-T1 level. This allowed for a more effective and stable sympathetic block with the use of a small injected volume. As an injection, we firstly used 1%-2.0 ml of lidocaine. The procedure will be continued by the injection of ethanol 50%, in quantity 1.5 ml for a lasting effect.
* Group B, thermal RF neurolysis will be applied with a time of 60 seconds at 80º C, and then will be repeated twice . Stellate ganglion RF therapy will be done under fluoroscopy, integrated by ultrasound guidance

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Post-mastectomy Pain Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Stellate ganglion block with alcohol injection

Stellate ganglion block with alcohol injection by ultrasound guidance and C7 level confirmation by fluoroscopy.

Group Type ACTIVE_COMPARATOR

thermal Radiofrequency neurolysis of Stellate ganglion

Intervention Type DEVICE

Stellate ganglion block with alcohol injection versus thermal RF neurolysis of Stellate ganglion

thermal RF neurolysis of Stellate ganglion

Stellate ganglion RF therapy will be done under fluoroscopy, integrated by ultrasound guidance

Group Type ACTIVE_COMPARATOR

thermal Radiofrequency neurolysis of Stellate ganglion

Intervention Type DEVICE

Stellate ganglion block with alcohol injection versus thermal RF neurolysis of Stellate ganglion

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

thermal Radiofrequency neurolysis of Stellate ganglion

Stellate ganglion block with alcohol injection versus thermal RF neurolysis of Stellate ganglion

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Stellate ganglion block with alcohol injection

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Female patient 20-65yrs underwent surgery for breast cancer
* Pain duration of more than 6 months
* Pain is moderate to severe pain (visual analog scale \[VAS\] ≥ 4 cm),
* Pain described as a refractory one that is defined as pain for which classic biomedical therapy has proven ineffective
* Pain is of positive neuropathic character as detected by the grading system for neuropathic pain (GSNP), with a score of 3 or 4

Exclusion Criteria

* Refusal of the patient
* Recent myocardial infarction
* Anti-coagulated patients or coagulopathy (evaluate risk/benefit ratio)
* Glaucoma
* Pre-existing counter lateral nerve palsy
* Severe emphysema
* Cardiac conduction block
* Local and systemic sepsis
* Local anatomical distortion (which may render the block technically difficult or hazardous.
* Psychiatric illness.
Minimum Eligible Age

20 Years

Maximum Eligible Age

65 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Cancer Institute, Egypt

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

suzan adlan, lecturer

Role: PRINCIPAL_INVESTIGATOR

National Cancer Institute, Egypt

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

NCIEgypt IRB office

Cairo, , Egypt

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

suzan adlan, lecturer

Role: CONTACT

01111068300

Taher Thabet, lecturer

Role: CONTACT

01225358877

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AP2212-501-027

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.